JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Otsuka, M.
Right arrow Articles by Endo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Otsuka, M.
Right arrow Articles by Endo, M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 128, Issue 3, 273-282, 1960
Copyright © 1960 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECT OF GUANIDINE ON NEUROMUSCULAR TRANSMISSION

M. Otsuka 1 and M. Endo 1

1 Department of Pharmacology, University of Tokyo, Japan

The effect of guanidine on neuromuscular transmission was studied in the sciatic-sartorius preparation of the frog, using intracellular electrodes. The sensitivity of the ned-plate to ACh was measured by applying ACh electrophoretically. Guanidine was also applied in the same way.

Guanidine greatly increased the amplitude of e.p.p. of curarized muscle without changing the resting potential at the end-plate region. Guanidine exhibited no effect on the cholinesterase activity, and it did not change the sensitivity of the end-plate to ACh. It is concluded that the drug increases the amplitude of e.p.p. by increasing the quantity of ACh released from the nerve ending by a single nerve impulse.

Membrane potential was recorded from endplates of guanidine-treated nerve-muscle preparation showing spontaneous twitchings. The most striking event was the appearance of spontaneous e.p.p.'s of more than 5 mV size (‘giant potential’), some of which did not reach threshold the others elicited the conducted action potentials.

When neuromuscular transmission was blocked with deploarizing agents, guanidine incedased the amplitude of e.p.p. to the point of cliciting a propagated action potential and muscle contraction.

As a possible mechanism, the increased presynaptic excitability and enhancement of the presynaptic excitation process were discussed.

Submitted on September 8, 1959







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1960 by the American Society for Pharmacology and Experimental Therapeutics.